NDC 51662-1620-01 - NALOXONE HCl

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51662-1620
Requested NDC: 51662-1620-01
Package NDCs from labels: 51662-1620-1, 51662-1620-2, 51662-1620-01
Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Effective date: 2024-01-28
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NALOXONE HCl - HF Acquisition Co LLC, DBA HealthFirst	HF Acquisition Co LLC, DBA HealthFirst	2024-01-28	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51662-1620-1	NALOXONE HCl	0.1 mL in 1 VIAL, SINGLE-DOSE	SPRAY	0.1	2
51662-1620-2	NALOXONE HCl	0.1 mL in 1 VIAL, SINGLE-DOSE	SPRAY	0.1	2
51662-1620-2	NALOXONE HCl	2 in 1 CARTON	SPRAY	2	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1620	NALOXONE HCL SPRAY [HF ACQUISITION CO LLC, DBA HEALTHFIRST]	2	Current NDC, 3 package rows	20240130_f8fcda15-8ba6-e66a-e053-6294a90a385c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 5 · 99 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Par Health USA, LLC	3ae08e26-223b-4971-b2f1-f1e183a3f930	2024-04-11	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
Naloxone Hydrochloride	NALXONE HYDROCHLORIDE	Hikma Pharmaceuticals USA Inc.	1bef59b9-7d51-4f19-a054-44b8eb6c6398	2024-04-10	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
naloxone hydrochloride	NALOXONE HYDROCHLORIDE	Lifestar Pharma LLC	ef647e2a-84e7-4e3e-942a-b6fc250141b6	2024-03-04	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	c72a60fb-196d-3f02-e053-2995a90ad906	2024-02-22	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
Narcan Naloxone HCL	NARCAN NALOXONE HCL	HF Acquisition Co LLC, DBA HealthFirst	11d770b8-b768-ba3d-e063-6394a90a61a6	2024-02-20	Warnings	Exact identifier unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	94ff1857-06da-7986-e053-2a95a90afb18	2024-02-19	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	c90e2d85-ed94-2c00-e053-2a95a90ad2a0	2024-01-30	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Actavis Pharma, Inc.	49350f7e-d613-40a8-8941-a2ec30eafdf3	2024-01-30	Warnings	Exact identifier rxcui: 1725059 unii: F850569PQR
NALOXONE HCl	NALOXONE HCL	HF Acquisition Co LLC, DBA HealthFirst	f8fcda15-8ba6-e66a-e053-6294a90a385c	2024-01-28	Warnings, Adverse reactions	Exact identifier application number: ANDA211951 ndc (package): 51662-1620-2 ndc (package): 51662-1620-1 ndc (product): 51662-1620 ndc11 (package): 51662162001 rxcui: 1725059 spl id: 100bc933-5bf3-8de2-e063-6294a90a7ba6 spl set id: f8fcda15-8ba6-e66a-e053-6294a90a385c unii: F850569PQR
NALOXONE HCI	NALOXONE HCI	HF Acquisition Co. LLC, DBA Health First	73c1bad3-6ac3-8682-e053-2a91aa0a176a	2024-01-27	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	e65e03c1-9a66-b30b-e053-2995a90aeb73	2024-01-27	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	HF Acquisition Co. LLC, DBA HealthFirst	74fc593e-ed47-efae-e053-2991aa0a5997	2024-01-25	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Teva Pharmaceuticals, Inc.	3a73ee4b-c2a4-496f-be90-9f78c8046062	2024-01-01	Warnings	Exact identifier rxcui: 1725059 unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	A-S Medication Solutions	46f27d04-d4d2-4ef1-9cc5-4d58f4056f06	2023-12-27	Warnings	Exact identifier application number: ANDA211951 rxcui: 1725059 unii: F850569PQR
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE NASAL	A-S Medication Solutions	4517afa1-4b17-4a15-b91b-65b18bd0558f	2023-11-24	Warnings, Adverse reactions	Exact identifier rxcui: 1725059 unii: F850569PQR
NARCAN NALOXONE HCI	NARCAN NALOXONE HCI	HF Acquisition Co LLC, DBA HealthFirst	784a0e98-c2d6-f845-e053-2991aa0ac4b4	2023-10-10	Warnings, Adverse reactions	Exact identifier rxcui: 1725059 unii: F850569PQR
NALOXONE HYDROCHLORIDE	NALOXONE HYDROCHLORIDE	A-S Medication Solutions	0b3b5214-6f91-4bba-82d6-d57b16845df5	2023-10-01	Warnings, Adverse reactions	Exact identifier application number: ANDA211951 rxcui: 1725059 unii: F850569PQR
NARCAN	NALOXONE HYDROCHLORIDE	A-S Medication Solutions	139c30b9-5600-48f5-8610-0cacd2782398	2023-09-28	Warnings, Adverse reactions	Exact identifier rxcui: 1725059 unii: F850569PQR
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	Hospira, Inc.	b598c237-032d-4bb5-0e92-50eabd863dac	2023-06-04	Warnings, Adverse reactions	Exact identifier unii: F850569PQR
Naloxone Hydrochloride	NALOXONE HYDROCHLORIDE	A-S Medication Solutions	3d2dcee4-7510-477b-95a8-9b2afb773984	2023-05-23	Warnings, Adverse reactions	Exact identifier unii: F850569PQR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.